Approach to antiarrhythmic therapy in patients with ICDs and frequent activations
- Cite this article as:
- Pinter, A. & Dorian, P. Curr Cardiol Rep (2005) 7: 376. doi:10.1007/s11886-005-0092-5
Patients with an implantable defibrillator may require concomitant antiarrhythmic drug therapy to reduce therapy from the device, especially shocks from the device. New evidence suggests that amiodarone, in combination with β-blockade, is the most effective treatment to reduce the frequency of defibrillator therapies, but sotalol and azimilide have also been shown to be effective. Electrical storm is a serious condition that occurs in 20% of patients living with a defibrillator, and its management requires a complex approach to the patient.